Course Description
Patients with diabetes mellitus (DM) have increased risk for developing MDD and this relationship is bidirectional, with similar mechanisms linking the disease states. Guidelines and organizations provide recommendations for depression screening in patients with DM. Several studies evaluated the safety and efficacy of antidepressants for treatment of MDD in patients with DM. However, not all clinicians are familiar with the literature and may be uncertain about preferred depression monitoring and treatment options. This presentation will address how psychiatric pharmacists can help address this gap as psychotropic medication experts and provide recommendations. The presentation will also discuss why this overlap with MDD and DM is so common and how we can help destigmatize it. Knowledge about the treatment of these co-occurring conditions is beneficial so that patients receive proper treatment regardless of the setting in which they seek care.
Learning Objectives
- Create a diabetes distress or depression screening plan for patients with diabetes mellitus (DM) in the primary care setting.
- Recommend strategies to reduce stressors contributing to a patient's diabetes distress.
- Develop a plan to optimize treatment for patients with depression and DM.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
BCPPs desiring an evidence-based focus on an emerging area of practice and contemporary issues in psychiatric pharmacy at the specialist level are the intended audience of this recertification activity. This activity is designed for BCPPs who learn best from didactic presentations, are auditory and visual learners, and/or who learn best from hands-on-learning and dialoguing with specialist faculty and colleagues.
Faculty
View biographical information
Benjamin Chavez, PharmD, BCPP, BCACP
Clinical Pharmacist
Salud Family Health
Arvada, CO
Benjamin Chavez, PharmD, BCPP, BCACP practices as a clinical pharmacist at Salud Family Health Centers, an FQHC with thirteen locations across Colorado. He practices as a clinical pharmacist and serves as the Director of Behavioral Health Pharmacy Services at Salud Family Health Centers. He graduated with a PharmD from the University of Florida in 2004, and completed a psychiatric pharmacy residency at Nova Southeastern University. He is board certified in both psychiatric pharmacy and ambulatory care pharmacy, and has practiced in a variety of settings, including inpatient and outpatient psychiatry. His current focus is in outpatient primary care and behavioral health, at Salud Family Health Center. There he practices under Collaborative Practice Agreements to treat depression, anxiety, bipolar disorder, as well as chronic disease states such as diabetes and hypertension.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Date: 10/12/2023
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-23-015-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View disclaimer and disclosure of off-label use
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
View fair balance and integrity statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.